Profile | GDS4284 / 225373_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1671.44 | 81 |
GSM687648 | Patient 402 control | 4644.63 | 93 |
GSM687653 | Patient 403 control | 1436.7 | 79 |
GSM687658 | Patient 404 control | 3674.39 | 91 |
GSM687663 | Patient 411 control | 3919.05 | 91 |
GSM687668 | Patient 422 control | 2566.73 | 87 |
GSM687673 | Patient 424 control | 3546.59 | 91 |
GSM687678 | Patient 425 control | 4091.01 | 92 |
GSM687683 | Patient 427 control | 2802.03 | 88 |
GSM687688 | Patient 428 control | 2683.51 | 87 |
GSM687695 | Patient 441 control | 13135.6 | 98 |
GSM687699 | Patient 443 control | 4782.22 | 93 |
GSM687704 | Patient 444 control | 3134.44 | 89 |
GSM687707 | Patient 448 control | 1397.53 | 79 |
GSM687712 | Patient 449 control | 1680.82 | 82 |
GSM687719 | Patient 450 control | 4408.84 | 92 |
GSM687724 | Patient 451 control | 1426.85 | 80 |
GSM687728 | Patient 452 control | 7246.36 | 96 |
GSM687646 | Patient 401 treated 24h | 1553.73 | 80 |
GSM687649 | Patient 402 treated 24h | 4130.7 | 92 |
GSM687665 | Patient 411 treated 24h | 4500.88 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 4710.29 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 2594.95 | 87 |
GSM687670 | Patient 422 treated 24h | 2430.46 | 86 |
GSM687671 | Patient 422 treated 4 weeks | 2432.16 | 86 |
GSM687654 | Patient 403 treated 24h | 1636.68 | 81 |
GSM687675 | Patient 424 treated 24h | 3559.2 | 91 |
GSM687685 | Patient 427 treated 24h | 3634.65 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 1546.16 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 3021.47 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 2001.82 | 83 |
GSM687692 | Patient 428 treated 4h | 2607.11 | 87 |
GSM687716 | Patient 449 treated 4h | 1529.01 | 80 |
GSM687722 | Patient 450 treated 4h | 3576.67 | 91 |
GSM687680 | Patient 425 treated 24h | 3211.22 | 89 |
GSM687690 | Patient 428 treated 24h | 2498.59 | 87 |
GSM687700 | Patient 443 treated 24h | 8156.1 | 96 |
GSM687705 | Patient 444 treated 24h | 3545.13 | 90 |
GSM687714 | Patient 449 treated 24h | 1507.66 | 80 |
GSM687721 | Patient 450 treated 24h | 4914.95 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 3786.02 | 91 |
GSM687694 | Patient 428 treated 4 weeks | 3166.03 | 89 |
GSM687702 | Patient 443 treated 4 weeks | 3290.04 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 1737.04 | 82 |
GSM687723 | Patient 450 treated 4 weeks | 2623.76 | 87 |
GSM687661 | Patient 404 treated 4h | 2618.96 | 87 |
GSM687710 | Patient 448 treated 4h | 1652.93 | 82 |
GSM687726 | Patient 451 treated 4h | 1236.91 | 77 |
GSM687730 | Patient 452 treated 4h | 8338.52 | 97 |
GSM687660 | Patient 404 treated 24h | 13997.5 | 98 |
GSM687697 | Patient 441 treated 24h | 12809.1 | 98 |
GSM687709 | Patient 448 treated 24h | 1574.7 | 81 |
GSM687725 | Patient 451 treated 24h | 1359.67 | 79 |
GSM687729 | Patient 452 treated 24h | 12542.8 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 1655.38 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 5738.22 | 94 |